Cardioprotection Via Activation of Protein Kinase C-δ Depends on Modulation of the Reverse Mode of the Na + /Ca 2+ Exchanger

Background— Pretreatment with the volatile anesthetic sevoflurane protects cardiomyocytes against subsequent ischemic episodes caused by a protein kinase C (PKC)-δ mediated preconditioning effect. Sevoflurane directly modulates cardiac Ca 2+ handling, and because Ca 2+ also serves as a mediator in o...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Circulation (New York, N.Y.) N.Y.), 2006-07, Vol.114 (1_supplement)
Hauptverfasser: Bouwman, R. Arthur, Salic, Kanita, Padding, F. Gieneke, Eringa, Etto C., van Beek-Harmsen, Brechje J., Matsuda, Toshio, Baba, Akemichi, Musters, René J.P., Paulus, Walter J., de Lange, Jaap J., Boer, Christa
Format: Artikel
Sprache:eng
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Background— Pretreatment with the volatile anesthetic sevoflurane protects cardiomyocytes against subsequent ischemic episodes caused by a protein kinase C (PKC)-δ mediated preconditioning effect. Sevoflurane directly modulates cardiac Ca 2+ handling, and because Ca 2+ also serves as a mediator in other cardioprotective signaling pathways, possible involvement of the Na + /Ca 2+ exchanger (NCX) in relation with PKC-δ in sevoflurane-induced cardioprotection was investigated. Methods and Results— Isolated right ventricular rat trabeculae were subjected to simulated ischemia and reperfusion (SI/R), consisting of superfusion with hypoxic glucose-free buffer for 40 minutes after rigor development, followed by reperfusion with normoxic glucose containing buffer. Preconditioning with sevoflurane before SI/R improved isometric force development during contractile recovery at 60 minutes after the end of hypoxic superfusion (83±7% [sevo] versus 57±2% [SI/R];n=8; P
ISSN:0009-7322
1524-4539
DOI:10.1161/CIRCULATIONAHA.105.000570